middle.news
Island Pharmaceuticals Secures US Patent for Galidesivir to Combat Deadly Filoviruses
9:52am on Wednesday 7th of January, 2026 AEDT
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Secures US Patent for Galidesivir to Combat Deadly Filoviruses
9:52am on Wednesday 7th of January, 2026 AEDT
Key Points
US Patent Number 12,508,266 granted for Galidesivir’s use against filoviridae viruses
Patent protection extends through October 2031
Targets high-priority viruses such as Marburg and Ebola
Supports Island’s clinical development and FDA regulatory pathway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE